What Is Retatrutide?
Retatrutide is a multi agonist peptide designed to activate GLP 1, GIP, and glucagon receptors. It was developed for broad metabolic research interest tied to obesity, Type 2 diabetes, and cardiovascular risk reduction endpoints.
Mechanisms of Action
Multi receptor agonism that activates GLP 1, GIP, and glucagon signaling, amplifying glucose regulation signals, energy expenditure, and fat metabolism.
Appetite suppression signaling that reduces hunger and increases satiety via central appetite regulation pathways, supporting sustained caloric reduction.
Metabolic regulation signaling that may improve insulin sensitivity, support lipid metabolism, and increase total energy expenditure, contributing to bodyweight reduction and metabolic health endpoints.
Benefits
Significant body fat reduction signals, with reported efficacy exceeding single pathway GLP 1 or GIP agonism in comparative research discussion.
Improved glycemic control signals through lower blood glucose and improved outcomes in Type 2 diabetes or metabolic syndrome models.
Cardiovascular risk factor improvement signals including reductions in LDL cholesterol, triglycerides, and blood pressure, supporting overall heart health endpoints.
Dosing
Level | Weekly Dose (mg) |
|---|---|
Low | 1 to 4 mg per week |
Average | 5 to 8 mg per week |
High | 9 to 12 mg per week |
Retatrutide can dosing can be split up 2-3x a week to minimize side effects and achieve steadier levels. Dosing starts at 1mg and is titrated up until optimal dosage is found.
Safety Profile
Retatrutide is generally described as well tolerated, but common observations discussed with GLP 1 based therapies can include mild to moderate gastrointestinal discomfort such as nausea, diarrhea, and bloating, especially during dose escalation. Potential risks may include gallbladder issues (including gallstones or cholecystitis) or pancreatitis in susceptible individuals, plus transient fatigue or dizziness as the body adjusts. Individuals with a history of pancreatitis, gallbladder disease, or severe gastrointestinal conditions are typically treated as higher monitoring priority. Educational only, not medical advice.
Stacking
Fat Loss Stack
Retatrutide
L-Carnitine
5-Amino-1MQ
SLU-PP-332
HGH or GH Secretagogues
Insulin Sensitivity Stack
Retatrutide
MOTS-c
5-Amino-1MQ
Max Anabolism + Fat Loss
Retatrutide
Testosterone Cypionate or Enthanate or Enclomophine
HGH or GH Secretagogues
Disclaimer: The information provided is intended solely for educational purposes and should not be considered a replacement for professional medical advice. All compounds referenced are not for human consumption.
Retatrutide
Get Sourcing Info
Enter your email to receive exclusive sourcing information for this compound.
Research use only, not for human consumption.
No spam, unsubscribe anytime.